Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor
暂无分享,去创建一个
Harel Weinstein | Stuart C. Sealfon | H. Weinstein | S. Sealfon | B. J. Ebersole | I. Visiers | Cassandra Prioleau | Irache Visiers | Barbara J. Ebersole | C. Prioleau
[1] U. Kumar,et al. The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization* , 1998, The Journal of Biological Chemistry.
[2] L. Slice,et al. The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.
[3] B. Kobilka,et al. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. , 2001, The Journal of pharmacology and experimental therapeutics.
[4] L. Hunyady,et al. A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor (*) , 1995, The Journal of Biological Chemistry.
[5] E. sanders-Bush,et al. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. , 1995, Molecular pharmacology.
[6] E. Freire,et al. The propagation of binding interactions to remote sites in proteins: analysis of the binding of the monoclonal antibody D1.3 to lysozyme. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Payan,et al. Identification of Potential Tyrosine-containing Endocytic Motifs in the Carboxyl-tail and Seventh Transmembrane Domain of the Neurokinin 1 Receptor* , 1997, The Journal of Biological Chemistry.
[8] S. Miura,et al. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). , 1998, Biochemistry.
[9] H. Weinstein,et al. The Functional Microdomain in Transmembrane Helices 2 and 7 Regulates Expression, Activation, and Coupling Pathways of the Gonadotropin-releasing Hormone Receptor* , 1999, The Journal of Biological Chemistry.
[10] P Ghanouni,et al. Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor* , 2001, The Journal of Biological Chemistry.
[11] J W Saldanha,et al. Transmembrane Domains 4 and 7 of the M1Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch* , 2001, The Journal of Biological Chemistry.
[12] K. Hofmann,et al. Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Maigret,et al. Control of Conformational Equilibria in the Human B2 Bradykinin Receptor , 2001, The Journal of Biological Chemistry.
[14] S. Nickolls,et al. Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction , 2001, The Journal of Biological Chemistry.
[15] Harel Weinstein,et al. Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.
[16] R. Leduc,et al. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. , 1996, Molecular pharmacology.
[17] R. Nussinov,et al. Folding funnels and binding mechanisms. , 1999, Protein engineering.
[18] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.
[19] M. Grotewiel,et al. Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptors revealed by heterologous expression , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[20] Elaine C. Meng,et al. An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.
[21] M. Caron,et al. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.
[22] M. Brann,et al. The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling* , 1998, The Journal of Biological Chemistry.
[23] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[24] H Weinstein,et al. Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.
[25] J. Wess,et al. Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy* , 2002, The Journal of Biological Chemistry.
[26] O. Lichtarge,et al. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. , 1999, The Journal of biological chemistry.
[27] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[28] K. Palczewski,et al. Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.
[29] R. Zare,et al. Single-molecule spectroscopy of the β2 adrenergic receptor: Observation of conformational substates in a membrane protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Hulme,et al. A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor* , 2000, The Journal of Biological Chemistry.
[31] T. Gudermann,et al. A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G‐protein coupling , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] J. Dias,et al. Structural biology of human follitropin and its receptor. , 2001, Archives of medical research.
[33] R. Graham,et al. Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. , 2002, Biochemistry.
[34] J. Stankova,et al. Structural and Functional Requirements for Agonist-induced Internalization of the Human Platelet-activating Factor Receptor* , 1997, The Journal of Biological Chemistry.
[35] P Ghanouni,et al. Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Ballesteros,et al. Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage* , 2002 .
[37] H Weinstein,et al. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.
[38] H Weinstein,et al. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.
[39] K Konvicka,et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.
[40] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[41] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[42] A. Fersht,et al. Protein engineering and the study of structure--function relationships in receptors. , 1990, Trends in pharmacological sciences.
[43] T. Schwartz,et al. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Caron,et al. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. , 1994, The Journal of biological chemistry.
[45] J. Saldanha,et al. Seven-transmembrane receptors: crystals clarify. , 2002, Trends in pharmacological sciences.
[46] K. Konvička,et al. A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. , 1998, Biophysical journal.
[47] P. Leff,et al. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.
[48] R. Vogel,et al. Conformation and stability of alpha-helical membrane proteins. 1. Influence of salts on conformational equilibria between active and Inactive states of rhodopsin. , 2002, Biochemistry.
[49] J. Anderson,et al. A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. , 1997, Molecular pharmacology.
[50] A. Jesaitis,et al. Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein* , 1999, The Journal of Biological Chemistry.
[51] M. Caron,et al. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. , 1995, Biochemistry.
[52] A. Saltzman,et al. Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. , 1991, Biochemical and biophysical research communications.
[53] H. Weinstein,et al. Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. , 2001, Biochemistry.
[54] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[55] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[56] M. Struthers,et al. G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin. , 2000, Biochemistry.
[57] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[58] Martin J. Lohse,et al. Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions , 1996 .
[59] C. Chew,et al. Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. , 1998, American journal of physiology. Cell physiology.
[60] Robert P. Millar,et al. Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[61] G. Liapakis,et al. Constitutive Activation of the β2 Adrenergic Receptor Alters the Orientation of Its Sixth Membrane-spanning Segment* , 1997, The Journal of Biological Chemistry.
[62] J. Ballesteros,et al. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.
[63] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[64] E. sanders-Bush,et al. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. , 1994, The Journal of biological chemistry.
[65] Bryan L Roth,et al. Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6* 210 , 2002, The Journal of Biological Chemistry.
[66] Alan R. Fersht,et al. The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus) , 1984, Cell.
[67] Marvin Wickens,et al. Analyzing mRNA-protein complexes using a yeast three-hybrid system. , 2002, Methods.
[68] S. Sealfon,et al. Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor. , 2000, Brain research. Molecular brain research.
[69] H. Weinstein,et al. Molecular Dynamics Simulation of Membranes and a Transmembrane Helix , 1999 .
[70] Y. Shichida,et al. Heterogeneity of rhodopsin intermediate state interacting with transducin. , 2000, Methods in enzymology.
[71] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[72] D. Oprian,et al. Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore , 1991, Science.
[73] T. Kenakin,et al. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.